SEC Form 4 · accession 0001209191-15-064393
QUAKER CHEMICAL CORP · KWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret M Loebl
Officer — VP, CFO and Treasurer
Period of report
Aug 4, 2015
Accepted (ET)
Aug 6, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000081362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 4, 2015 | M | 2,192 | $46.21 | A | 9,017 | D | |
| Common StockF1 | Aug 4, 2015 | S | 2,192 | $92.1565 | D | 6,825 | D | |
| Common Stock | Aug 4, 2015 | M | 1,420 | $58.26 | A | 8,245 | D | |
| Common StockF2 | Aug 4, 2015 | S | 1,420 | $92.5613 | D | 6,825 | D | |
| Common Stock | Aug 4, 2015 | M | 842 | $73.47 | A | 7,667 | D | |
| Common StockF3 | Aug 4, 2015 | S | 842 | $91.392 | D | 6,825 | D | |
| Common StockF4 | holding | — | — | — | 481 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $46.21 | Aug 4, 2015 | M | 2,192 | D | Jun 29, 2013 | Jun 29, 2019 | Common Stock | 2,192 | 0 | D |
| Employee Stock Option (right to buy)F6 | $58.26 | Aug 4, 2015 | M | 1,420 | D | Mar 5, 2014 | Mar 5, 2020 | Common Stock | 1,420 | 710 | D |
| Employee Stock Option (right to buy)F7 | $73.47 | Aug 4, 2015 | M | 842 | D | Feb 27, 2015 | Feb 27, 2021 | Common Stock | 842 | 1,683 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.53 to $92.50, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.50 to $92.67, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.16 to $91.53, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- F4Information based on reporting person's Plan statement as of June 30, 2015.
- F5The options for this grant vested in three annual installments: 731 shares on June 29, 2013; 731 shares on June 29, 2014; and 730 shares on June 29, 2015.
- F6The options for this grant vest in three annual installments: 710 shares on March 5, 2014; 710 shares on March 5, 2015; and 710 shares on March 5, 2016.
- F7The options for this grant vest in three annual installments: 842 shares on February 27, 2015; 842 shares on February 27, 2016; and 841 shares on February 27, 2017.